FATP2 Monoclonal antibody

FATP2 Monoclonal Antibody for IHC, WB, ELISA

Host / Isotype

Mouse / IgG1

Reactivity

Human, rat

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

CloneNo.

2C10D7

Cat no : 68074-1-Ig

Synonyms

ACSVL1, FACVL1, FATP 2, FATP2, Fatty acid transport protein 2, hFACVL1, HsT17226, SLC27A2, THCA CoA ligase, VLACS, VLCS



Tested Applications

Positive WB detected inA549 cells, HepG2 cells, rat liver tissue, LNCaP cells, HeLa cells
Positive IHC detected inhuman kidney tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunohistochemistry (IHC)IHC : 1:250-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

68074-1-Ig targets FATP2 in WB, IHC, ELISA applications and shows reactivity with Human, rat samples.

Tested Reactivity Human, rat
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen FATP2 fusion protein Ag5390
Full Name solute carrier family 27 (fatty acid transporter), member 2
Calculated Molecular Weight 567 aa, 65 kDa
Observed Molecular Weight 70 kDa
GenBank Accession NumberBC057770
Gene Symbol SLC27A2
Gene ID (NCBI) 11001
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

FATP2 is a member of the FATP family which functions in lipid and bile metabolism. It is a 70-kDa protein predominantly expressed in liver and kidney. Kidney FATP2 is localized exclusively to proximal tubule epithelial cells along the apical but not the basolateral membrane, and regulates lipoapoptosis. FATP2 is involved in metabolism-related diseases including nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM), and is a potential clinical biomarker and therapeutic target.

Protocols

Product Specific Protocols
WB protocol for FATP2 antibody 68074-1-IgDownload protocol
IHC protocol for FATP2 antibody 68074-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols